I now have all the required information. Here is my consolidated final review.

---

## Summary

This paper applies transfer learning with two pre-trained CNNs (ResNet-50 and EfficientNetV2) to classify kidney conditions (cysts, stones, tumors, normal) from CT scans using four binary classification tasks. The core empirical claim is that EfficientNetV2 achieves perfect (100%) or near-perfect testing accuracy across all four tasks, substantially exceeding prior results in the area. The paper offers no new architecture or training methodology — it fine-tunes off-the-shelf models on a public Kaggle dataset.

## Strengths

- **Four-binary-classification framework** (Cyst vs Normal, Cyst vs Stone, Cyst vs Tumor, Stone vs Tumor) is a reasonable organizational choice that allows more targeted differential diagnosis compared to a single multi-class classifier. This is described in the Abstract and Section 3.3.

- **Head-to-head comparison of ResNet-50 and EfficientNetV2 under identical training conditions**, reported with ROC curves and precision/recall metrics (Section 3.4, Figure 7). While standard practice, this gives a clear architectural comparison for the specific tasks.

- **Use of a real clinical dataset sourced from a hospital PACS in Bangladesh** (Section 3.1), which adds practical relevance relative to purely synthetic benchmarks.

## Weaknesses

### Fatal

None that are verifiable as fatal from the paper alone. The concerns below are serious but require verification that goes beyond what is on the page.

### Major

- **Implausible near-perfect accuracy with no patient-level split information.** The paper reports 100% testing accuracy for EfficientNetV2 across three of four binary tasks and "perfect or near-perfect" accuracy for ResNet-50 (Section 3.4, lines 85–86). On real-world medical CT data with 3,360–8,786 images per task, such results are extremely unusual and strongly suggest evaluation leakage. The paper never states whether the train/validation/test split was performed at the **patient level** (same-patient images across splits) — a standard requirement in medical imaging to avoid data leakage. No deduplication, image hashing, or patient-ID-based splitting is described. Without this information, the core empirical claim lacks credibility. (Verifiable: the paper discusses dataset splits in lines 39 and 70 but never mentions patient-level separation.)

- **No comparison against prior methods or simple baselines.** The Related Work section (Section 2, line 21) cites prior kidney disease classification studies with accuracies of 84%–98%, yet the paper compares only ResNet-50 vs. EfficientNetV2. It does not reproduce any of those prior methods on the same dataset, nor include even a simple baseline (e.g., linear classifier on hand-crafted features, CNN trained from scratch). Without such comparisons, there is no way to assess whether the transfer learning approach offers any improvement over existing work. (Verifiable: the experimental section mentions only the two models; no prior method is re-implemented.)

- **Thin methodological contribution relative to the framing.** The paper applies standard pre-trained CNNs (ResNet-50, EfficientNetV2) with standard fine-tuning to a public Kaggle dataset. It introduces no new architecture, training strategy, domain-specific handling (e.g., small lesion detection, class imbalance), or model interpretability analysis. The paper frames this as a "comprehensive classification framework" and "deep learning framework" (Abstract, line 4), which overstates what is fundamentally a standard transfer-learning application. (Verifiable: Sections 3.2–3.4 describe only off-the-shelf architectures with ImageNet pretraining.)

### Minor

- **Weight initialization section (3.2) is misaligned with the actual methodology.** The paper devotes significant space (lines 49–61) to deriving Xavier and He initialization formulas and discussing their properties, but the models are initialized with **pre-trained ImageNet weights** via transfer learning (line 63). The initialization derivations are irrelevant to the actual experiment and create confusion about whether the models were trained from scratch. (Verifiable: Section 3.2 contains both the initialization discussion and a separate TL subsection; the TL subsection states pre-trained weights are used.)

- **Short training schedule with best-epoch selection on validation data.** Training runs for only 10 epochs with best weights selected based on validation accuracy (lines 70, 81). For medical imaging transfer learning, 10 epochs is unusually short, and picking the best validation epoch optimistically biases the reported performance. The paper does not discuss whether validation loss was increasing (indicating overfitting) in later epochs — though Figures 3b and 4b are described as showing fluctuations and rising validation loss for some tasks (line 81).

- **No data augmentation.** The paper does not mention any data augmentation (verified: grep for "augment" returns no matches). This is standard practice in medical imaging to improve generalization, and its absence is notable, especially given the small dataset sizes.

- **No error analysis or model interpretability.** With claims of perfect/near-perfect accuracy, the paper should analyze the few misclassifications (e.g., what distinguishes them, whether they are ambiguous cases). No such analysis is provided. The paper also mentions interpretability only as future work (line 103).

- **No discussion of class balance.** For each binary task, the per-class image counts are not reported. If classes are imbalanced, high accuracy can be achieved trivially. (Verifiable: line 39 gives only total images per task.)

- **Non-standard "256 iterations per epoch" definition.** The paper fixes 256 iterations per epoch regardless of dataset size (line 70). For the smallest dataset (3,360 images), this could mean multiple passes through the training data within a single "epoch," which is inconsistent with standard terminology and makes the training protocol unclear.

### Trivial

- Line 103: "future work is needed to inflate the robustness" — "inflate" should be "enhance" or "improve."
- At line 4, the abstract mentions "CT scans and microscopic histopathology images," but the paper only uses CT scans.
- The paper states EfficientNetV2 achieves "perfect accuracy for all tasks and near-perfect accuracy in the Cyst vs Stone" (line 86) — a direct internal contradiction: if accuracy is perfect for all tasks, then Cyst vs Stone cannot be near-perfect.

## Nice-to-Haves

- Including Grad-CAM or similar interpretability maps would strengthen the clinical plausibility of the claimed accuracy.
- Reporting confidence intervals or standard deviations across multiple runs would be informative.
- Expanding the analysis to multi-institutional data or external validation would increase generalizability.

## Removed Points

These points are flagged to be removed — treat them with caution.

- **"The paper should not be accepted in its current form" / "A revision could potentially salvage"** — These are evaluative conclusions, not specific weaknesses. They are incorporated into the overall assessment.
- **"The contribution is trivial even if the results were accepted"** — Kept in modified form as "thin methodological contribution" above, but the "trivial" framing is softened since it is partly subjective and the paper does not hide what it does.
- **"Section 2 reads as a disconnected literature summary"** — This is an opinion about writing quality; the paper does list relevant prior work.
- **Strength Finder's Strength 1** ("Achieves SOTA accuracy up to 100%") — Removed because this restates the paper's own questionable claim as a strength, and the weakness about implausible accuracy conflicts with it.
- **Strength Finder's Strength about "mathematical detail on weight initialization" (Supporting Strength 2)** — Removed because the initialization discussion is misaligned with the actual methodology (verified weakness), so it does not constitute a genuine strength.
- **Strength Finder's Strength 3** ("Provides thorough head-to-head comparison") — Retained in modified form; the original framing overstated its significance.

## Novel Insights

None beyond the paper's own contributions. The reviewer inputs did not identify any novel angle or overlooked implication that the paper itself fails to articulate.

## Suggestions

1. **Redo the evaluation with patient-level splits** and report cross-validated performance (mean ± std across folds). This is the single most important fix to make the results credible.
2. **Re-implement at least one prior method** from the Related Work section on the same dataset to provide a meaningful baseline.
3. **Report per-class counts** for each binary task and discuss any class imbalance.
4. **Add standard data augmentation** (rotation, flipping, scaling) and justify the choice of training hyperparameters.
5. **Provide error analysis** — even if accuracy is 99%+, discuss the misclassified cases and what they suggest about model limitations.
6. **Remove or substantially shorten Section 3.2** on weight initialization, since it does not reflect the actual method used.

## Score and Decision

The paper applies standard pre-trained CNNs to a public medical dataset and reports near-perfect accuracy without patient-level splitting, comparison to prior methods, data augmentation, or error analysis. The core empirical claim is not credible as presented, and the methodological contribution is modest. Significant revisions are needed before the work can be evaluated fairly.

**Originality:** Low — standard transfer learning application.  
**Importance of research question:** Moderate — kidney disease diagnosis is clinically important.  
**Claims supported by evidence:** No — the central accuracy claim is not backed by a credible evaluation protocol.  
**Soundness of experiments:** Weak — missing patient-level splits, no baseline comparison, no cross-validation, no data augmentation.  
**Clarity of writing:** Adequate but with several confusions (e.g., initialization section irrelevant to method, contradictory accuracy statements).  
**Value to the community:** Low — would not advance the field in its current form.

MY FINAL SCORE: <score>2.5</score>
MY FINAL DECISION: <decision>Reject</decision>